SPACInsider Logo
BlueRiver Adds Non-Redemption Agreement, Signs Non-Binding LOI
by Marlena Haddad on 2023-01-25 at 5:58pm

BlueRiver Acquisition Corp. (NYSE:BLUA) announced in an 8-K filing this afternoon that it has entered into a non-redemption agreement with one or more unaffiliated third parties after signing a non-binding letter of intent (LOI) yesterday.

Under the non-redemption agreement, the third parties agreed not to redeem an aggregate of 200,000 shares of BLUA. In exchange for the commitment not to redeem such shares, BlueRiver’s sponsor agreed to transfer an aggregate of 50,000 shares of the company to the investors immediately following the completion of the business combination.

BlueRiver currently faces a completion deadline of February 2, but is hoping to gain shareholder approval at its upcoming meeting on January 31 to extend its timeline to August 2. Although the parties have the non-redemption agreement in hand, the SPAC does not expect it to increase the likelihood that its extension proposal will be approved by shareholders, but will increase the amount of funds that remain in the company’s trust account following the meeting.

The agreement comes just a day after the company announced that it has signed a non-binding LOI with a target company. BlueRiver kept the details on the possible merger to a minimum, but disclosed that the target is focused on the medical technology sector.

Additionally, if the extension is implemented, the company plans to liquidate the U.S. government treasury obligations or money market funds held in the trust and thereafter to maintain the funds in an interest-bearing demand deposit account at a bank. Interest on the deposit account is currently 2.5% per annum.

Since BLUA’s deal is not at the “definitive agreement” stage, and is still just a non-binding LOI, SPACInsider will not consider this deal fully “announced”. As such, it will remain in the “Searching” category until a definitive agreement is signed.


Recent Posts
by Kristi Marvin on 2023-01-28 at 1:59pm

Terms Tracker for the Week Ending January 27, 2022 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We’re coming up on the end of January, the first month of the year, and to-date no new S-1s have been filed. Additionally, the number...

by Marlena Haddad on 2023-01-27 at 11:34am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: Circle spokesperson denies blaming SEC for failed deal, BuzzFeed CEO says AI-powered content will be part of core business, and FaZe Clan faces possible delisting Circle Spokesperson Denies Blaming SEC for Failed $9 Billion Deal...

by Nicholas Alan Clayton on 2023-01-27 at 10:00am

Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26. HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change.  However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20...

by Kristi Marvin on 2023-01-27 at 7:33am

Carbon capture technology has long been talked about, and it is finally in operation with LanzaTech among the pioneers. Its plants are turning potential emissions into clothing, household goods and sustainable fuels. SPAC cash is now also an accelerant in this new process as the company announced a $1.7 billion combination with AMCI II last March. This week, we caught up with...

by Nicholas Alan Clayton on 2023-01-27 at 7:30am

In this series we’ll be examining successful SPAC deals from the past both in the terms and circumstances of their de-SPAC processes and how they have weathered the storms that have followed after their public listings with research from SPACInsider contributor Anthony Sozzi. Thirty months does not sound like that long, but it’s been a...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved